Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNF-a | 21.0 | 81 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNF-a | 33.5 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNF-a | 90.0 | 56 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | TNF-a | 85.0 | 70 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNF-a | 52.0 | 87 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | TNF-a | 65.0 | 64 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNF-a | 98.5 | 60 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | TNF-a | 98.0 | 58 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 23.0 | 60 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 26.0 | 79 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 18.0 | 78 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 21.0 | 77 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 20.0 | 58 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 20.0 | 75 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 50.0 | 63 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 63.0 | 63 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 31.0 | 64 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 64.0 | 61 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 71.5 | 64 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 77.0 | 66 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | TNF-a | 23.0 | 59 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | TNF-a | 21.0 | 89 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | TNF-a | 20.0 | 67 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | TNF-a | 18.0 | 61 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | TNF-a | 21.0 | 47 |